Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.130x

Based on the latest financial reports, Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a cash flow conversion efficiency ratio of 0.130x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₫224.56 Billion ≈ $8.53 Million USD) by net assets (₫1.72 Trillion ≈ $65.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Binh Dinh Pharmaceutical and Medical Equipment JSC - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Binh Dinh Pharmaceutical and Medical Equipment JSC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read DBD current and long-term liabilities for a breakdown of total debt and financial obligations.

Binh Dinh Pharmaceutical and Medical Equipment JSC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Binh Dinh Pharmaceutical and Medical Equipment JSC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Radcom Ltd NASDAQ:RDCM	0.022x
Coveo Solutions Inc TO:CVO	0.005x
RADCOM Ltd F:RAM	N/A
Eaton Vance New York MBF NYSE MKT:ENX	0.037x
Marblegate Acquisition Corp NASDAQ:GATE	0.017x
Yatra Online Limited NSE:YATRA	-0.026x
Doktas Dokumculuk Ticaret ve Sanayi AS IS:DOKTA	0.129x
Digi Power X Inc. V:DGX	N/A

Annual Cash Flow Conversion Efficiency for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)

The table below shows the annual cash flow conversion efficiency of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Binh Dinh Pharmaceutical and Medical Equ market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₫1.72 Trillion ≈ $65.40 Million	₫626.26 Billion ≈ $23.79 Million	0.364x	+128.31%
2024-12-31	₫1.66 Trillion ≈ $63.11 Million	₫264.73 Billion ≈ $10.06 Million	0.159x	-22.33%
2023-12-31	₫1.43 Trillion ≈ $54.44 Million	₫293.99 Billion ≈ $11.17 Million	0.205x	+68.50%
2022-12-31	₫1.36 Trillion ≈ $51.49 Million	₫165.01 Billion ≈ $6.27 Million	0.122x	+18.13%
2021-12-31	₫1.14 Trillion ≈ $43.33 Million	₫117.57 Billion ≈ $4.47 Million	0.103x	-52.14%
2020-12-31	₫988.63 Billion ≈ $37.56 Million	₫212.91 Billion ≈ $8.09 Million	0.215x	--

About Binh Dinh Pharmaceutical and Medical Equipment JSC

VN:DBD Vietnam Drug Manufacturers - Specialty & Generic

Market Cap

$179.14 Million

₫4.72 Trillion VND

Market Cap Rank

#16952 Global

#108 in Vietnam

Share Price

₫49900.00

Change (1 day)

+0.30%

52-Week Range

₫48050.00 - ₫56700.00

All Time High

₫62000.00